2-98389666-C-T
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_001298.3(CNGA3):c.458C>T(p.Thr153Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0107 in 1,613,696 control chromosomes in the GnomAD database, including 101 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001298.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CNGA3 | NM_001298.3 | c.458C>T | p.Thr153Met | missense_variant | 6/8 | ENST00000272602.7 | NP_001289.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CNGA3 | ENST00000272602.7 | c.458C>T | p.Thr153Met | missense_variant | 6/8 | 1 | NM_001298.3 | ENSP00000272602 | A1 | |
CNGA3 | ENST00000436404.6 | c.404C>T | p.Thr135Met | missense_variant | 5/7 | 1 | ENSP00000410070 | P4 | ||
CNGA3 | ENST00000393503.2 | n.463C>T | non_coding_transcript_exon_variant | 2/2 | 4 | |||||
CNGA3 | ENST00000409937.1 | n.611C>T | non_coding_transcript_exon_variant | 6/8 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00825 AC: 1255AN: 152156Hom.: 3 Cov.: 32
GnomAD3 exomes AF: 0.00848 AC: 2133AN: 251484Hom.: 10 AF XY: 0.00870 AC XY: 1182AN XY: 135918
GnomAD4 exome AF: 0.0109 AC: 15967AN: 1461422Hom.: 98 Cov.: 31 AF XY: 0.0107 AC XY: 7774AN XY: 727012
GnomAD4 genome AF: 0.00824 AC: 1255AN: 152274Hom.: 3 Cov.: 32 AF XY: 0.00809 AC XY: 602AN XY: 74450
ClinVar
Submissions by phenotype
not provided Benign:4
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 06, 2021 | See Variant Classification Assertion Criteria. - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2024 | CNGA3: BS1, BS2 - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jan 27, 2016 | - - |
Achromatopsia 2 Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at